Prot #MBX-2H1002: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of MBX 2109 in Patients with Hypoparathyroidism (AVAIL Study)

Project: Research project

Project Details

StatusActive
Effective start/end date12/12/2412/12/27

Funding

  • PPD Investigator Services, LLC (Prot #MBX-2H1002 // Prot #MBX-2H1002)
  • MBX Biosciences, Inc (Prot #MBX-2H1002 // Prot #MBX-2H1002)